Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medolac Laboratories

Medolac Laboratories?uq=PEM9b6PF
2009 FOUNDED
PRIVATE STATUS
31-40 EMPLOYEES
Series C LATEST DEAL TYPE
$25M LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of human milk based nutritional and therapeutic products for preterm babies in hospital and after discharge to home. The company's proprietary biopharmaceutical processing methods has resulted in human milk products that can be shipped and stored at room temperature for up to 3 years, providing access to human donor milk for all babies in need by creating a more affordable, safer product that is easier to use for hospitals and families at home.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Food Products
Other Industries
Medical Supplies
Primary Office
  • 806 Buchanan Boulevard
  • 115-228
  • Boulder City, NV 89005
  • United States

+1 (866) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Medolac Laboratories’s full profile, request a free trial.

Medolac Laboratories Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 24-Jan-2017 $25M 000.00 0000 Completed Generating Revenue
4. Later Stage VC (Series B) 30-Jul-2015 000 00.00 0000 Completed Generating Revenue
3. Later Stage VC (Series A) 13-Oct-2014 00.00 00.00 000.00 Completed Startup
2. Grant 01-Jan-2010 $233K Completed Startup
1. Grant 01-Jan-2009 $114K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Medolac Laboratories Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00 00 00 00 00 00.000
Series B 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series A 2,057,149 $0.001000 6% $1.92 $1.92 1x $1.92 10.83%
To view this company’s complete Cap Table, request access »

Medolac Laboratories Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alan Doan Angel (individual) Minority 000 0000 000000 0
Investors' Circle Impact Investing Minority 000 0000 000000 0
PeakChange Other Minority 000 0000 000000 0

Medolac Laboratories Executive Team (7)

Name Title Board
Seat
Contact
Info
Elena Medo Co-Founder, Chief Executive Officer & Chairman
Jennifer Medo Vice President & General Manager
Donald Chace Ph.D Chief Scientific Officer
Adrianne Weir Co-Founder & Executive Vice President, Business Development
Aaron Medo Vice President, Facility & Production

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

Medolac Laboratories Board Members (5)

Name Representing Role Since Contact
Info
Alan Spitzer MD Self Board Member 000 0000
Elena Medo Medolac Laboratories Co-Founder, Chief Executive Officer & Chairman 000 0000
Karen Andrews JD Self Board Member 000 0000
Paul Feldstein Ph.D Self Board Member 000 0000
Tom Kalchik Medolac Laboratories Board Member 000 0000